Orion Corporation
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- ANTEPSIN tablet 1 g
- A06 - Agentes contra el estreñimiento
- TOILAX gastro-resistant tablet 5 mg
- TOILAX rectal suspension 10 mg/5 ml
- C01 - Terapia cardíaca
- SIMDAX concentrate for solution for infusion 12.5 mg/5 ml
- C03 - Diuréticos
- SPIRON tablet 100 mg
- SPIRON tablet 25 mg
- SPIRON tablet 50 mg
- C08 - Bloqueantes del canal de calcio
- CARDIL prolonged-release tablet 120 mg
- VERALOC RETARD prolonged-release tablet 200 mg
- J01 - Antibacterianos para uso sistémico
- PENOMAX film-coated tablet 200 mg
- N04 - Antiparkinsonianos
- COMTESS film-coated tablet 200 mg
- STALEVO film-coated tablet 100 mg+25 mg+200 mg
- STALEVO film-coated tablet 150 mg+37.5 mg+200 mg
- STALEVO film-coated tablet 50 mg+12.5 mg+200 mg
- N05 - Psicolépticos
- DEXDOR concentrate for solution for infusion 200 µg/2 ml
- DEXDOR concentrate for solution for infusion 400 µg/4 ml
- PERATSIN coated tablet 2 mg
- PERATSIN coated tablet 4 mg
- PERATSIN coated tablet 8 mg
- QUETIAPIN ORION film-coated tablet 100 mg
- QUETIAPIN ORION film-coated tablet 200 mg
- QUETIAPIN ORION film-coated tablet 25 mg
- QUETIAPIN ORION film-coated tablet 300 mg
- TRILAFON DEKANOAT solution for injection 108.2 mg/1 ml
- R03 - Agentes contra padecimientos obstructivos de las vías respiratorias
- BUFOMIX EASYHALER inhalation powder 4.5 µg/dose+160 µg/dose
- BUFOMIX EASYHALER inhalation powder 9 µg/dose+320 µg/dose